All Stories

  1. Poor efficacy of preemptive amoxicillin clavulanate for preventing secondary infection from Bothrops snakebites in the Brazilian Amazon: A randomized controlled clinical trial
  2. Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial
  3. Diagnostic tests for canine visceral leishmaniasis
  4. Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil
  5. Visceral Leishmaniasis and HIV Coinfection in Latin America
  6. G6PD deficiency in Latin America: systematic review on prevalence and variants
  7. Accuracy and reproducibility of a rapid chromatographic immunoassay for the diagnosis of canine visceral leishmaniasis in Brazil
  8. Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes
  9. Validity and Reliability of Enzyme Immunoassays Using Leishmania major or L. infantum Antigens for the Diagnosis of Canine Visceral Leishmaniasis in Brazil
  10. Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil
  11. Interventions for American Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review Update
  12. Congenitally transmitted visceral leishmaniasis: report of two Brazilian human cases
  13. Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil
  14. Clinical research monitoring: scenarios and challenges
  15. Development and validation of PCR-based assays for diagnosis of American cutaneous leishmaniasis and identificatio nof the parasite species
  16. Mediastinitis and pericardial effusion in a patient with AIDS and disseminated Mycobacterium avium infection: a case report
  17. Cost-effectiveness of diagnostic for malaria in Extra-Amazon Region, Brazil
  18. Multi-centric prospective evaluation of rk39 rapid test and direct agglutination test for the diagnosis of visceral leishmaniasis in Brazil
  19. Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients
  20. Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes
  21. Investigation of plant extracts in traditional medicine of the Brazilian Cerrado against protozoans and yeasts
  22. Control of Visceral Leishmaniasis in Latin America—A Systematic Review
  23. Detection of Leishmania kDNA in human serum samples for the diagnosis of visceral leishmaniasis
  24. Prevalence of Leishmania infection in adult HIV/AIDS patients treated in a tertiary-level care center in Brasilia, Federal District, Brazil
  25. Oportunidades perdidas de avaliação sorológica para a infecção pelo vírus da imunodeficiência humana na rotina de atendimento ambulatorial do Hospital Universitário de Brasília, Distrito Federal
  26. Sensitivity and reproducibility of a PCR assay for Leishmania detection using skin biopsy imprints on filter paper
  27. Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District
  28. Efeito de uma formulação hidrofílica de paromomicina tópica na leishmaniose cutânea em pacientes com contra-indicações de tratamento com antimonial pentavalente
  29. Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil
  30. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial
  31. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil
  32. Identification of antigenically distinct populations of Leishmania (Viannia) guyanensis from Manaus, Brazil, using monoclonal antibodies
  33. The rarity of infection withLeishmania (Viannia) braziliensisamong patients from the Manaus region of Amazonas state, Brazil, who have cutaneous leishmaniasis
  34. Sensitivity of the polymerase chain reaction for the diagnosis of cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis
  35. Comparison of Cutaneous Leishmaniasis Due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: Clinical Findings and Diagnostic Approach
  36. Glucantime dosage